Atractylodes lancea may have a therapeutic role in CRC through inhibiting cell proliferation and migration by targeting the hub genes (MMP3, MMP9, TIMP1 and VEGFA) though PI3K/AKT signaling pathway. The gene discussed is VEGFA; the disease is colorectal carcinoma.